| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |